Replimune (REPL) Enterprise Value (2018 - 2025)

Replimune has disclosed Enterprise Value across 8 years of filings, most recently posting -$269.1 million for Q4 2025.

• Enterprise Value for Q4 2025 came in at -$269.1 million, up 49.84% year-over-year; the trailing twelve-month figure through Dec 2025 was -$269.1 million (up 49.84% YoY), and the FY2025 annual result was -$483.8 million, down 15.01% from the prior year.
• Enterprise Value came in at -$269.1 million for Q4 2025 at Replimune, up from -$323.6 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$269.1 million in Q4 2025 to a low of -$616.4 million in Q4 2022.
• The 5-year median for Enterprise Value is -$447.1 million (2021), against an average of -$446.9 million.
• Across the five-year window, Enterprise Value tumbled 226.76% in 2021 and soared 49.84% in 2025, its largest moves.
• Replimune's Enterprise Value stood at -$420.2 million in 2021, then sank by 46.7% to -$616.4 million in 2022, then climbed by 24.34% to -$466.4 million in 2023, then fell by 15.05% to -$536.5 million in 2024, then jumped by 49.84% to -$269.1 million in 2025.
• The last three Enterprise Value figures came in at -$269.1 million (Q4 2025), -$323.6 million (Q3 2025), and -$403.3 million (Q2 2025), per Business Quant data.